Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia. (October 2013)
- Record Type:
- Journal Article
- Title:
- Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia. (October 2013)
- Main Title:
- Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia
- Authors:
- Nielsen, Thomas
Nielsen, Niels Chr.
Holm, Thomas H.
Østergaard, Leif
Horsman, Michael R.
Busk, Morten - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Background.</italic> Currently, radiation treatments are being optimised based on in vivo imaging of radioresistant, hypoxic tumour areas. This study aimed at detecting nicotinamide's reduction of acute hypoxia in a mouse tumour model by two clinically relevant magnetic resonance imaging (MRI) methods at ultra-high magnetic field strength. <italic>Material and methods.</italic> The C3H mammary carcinoma was grown to 200 mm<sup>3</sup> in the right rear foot of CDF<sub>1</sub> mice. The mice were anaesthetised with ketamine and xylazine prior to imaging. A treatment group received nicotinamide intraperitoneally (i.p.) at the dose 1000 mg/kg, and a control group received saline. MRI was performed at 16.4 T with a spatial resolution of 0.156 × 0.156 × 0.5 mm<sup>3</sup>. The imaging protocol included BOLD imaging and two DCE-MRI scans. Initial area under the curve (IAUC) and the parameters from the extended Toft's model were estimated from the DCE-MRI data. Tumour median values of 1) T<sub>2</sub>* mean, 2) T<sub>2</sub>* standard deviation, 3) DCE-MRI parameters, and 4) DCE-MRI parameter differences between scans were compared between the treatment groups using Student's t-test (significance level p &lt; 0.05). <italic>Results.</italic> Parametric maps showed intra- and inter-tumour heterogeneity. Blood volume was significantly larger in the nicotinamide-treated group, and also the blood volume difference between the two DCE-MRI<abstract> <title>Abstract</title> <p> <italic>Background.</italic> Currently, radiation treatments are being optimised based on in vivo imaging of radioresistant, hypoxic tumour areas. This study aimed at detecting nicotinamide's reduction of acute hypoxia in a mouse tumour model by two clinically relevant magnetic resonance imaging (MRI) methods at ultra-high magnetic field strength. <italic>Material and methods.</italic> The C3H mammary carcinoma was grown to 200 mm<sup>3</sup> in the right rear foot of CDF<sub>1</sub> mice. The mice were anaesthetised with ketamine and xylazine prior to imaging. A treatment group received nicotinamide intraperitoneally (i.p.) at the dose 1000 mg/kg, and a control group received saline. MRI was performed at 16.4 T with a spatial resolution of 0.156 × 0.156 × 0.5 mm<sup>3</sup>. The imaging protocol included BOLD imaging and two DCE-MRI scans. Initial area under the curve (IAUC) and the parameters from the extended Toft's model were estimated from the DCE-MRI data. Tumour median values of 1) T<sub>2</sub>* mean, 2) T<sub>2</sub>* standard deviation, 3) DCE-MRI parameters, and 4) DCE-MRI parameter differences between scans were compared between the treatment groups using Student's t-test (significance level p &lt; 0.05). <italic>Results.</italic> Parametric maps showed intra- and inter-tumour heterogeneity. Blood volume was significantly larger in the nicotinamide-treated group, and also the blood volume difference between the two DCE-MRI scans was significantly larger in the treatment group. <italic>Conclusion.</italic> Higher blood volume and blood volume variation was observed by DCE-MRI in the treatment group. Other DCE-MRI parameters showed no significant differences, and the higher blood volume was not detected by BOLD MRI. The higher blood volume variation seen with DCE-MRI may be influenced by the drug effect reducing over time, and furthermore the anaesthesia may play an important role.</p> </abstract> … (more)
- Is Part Of:
- Acta oncologica. Volume 52:Number 7(2013)
- Journal:
- Acta oncologica
- Issue:
- Volume 52:Number 7(2013)
- Issue Display:
- Volume 52, Issue 7 (2013)
- Year:
- 2013
- Volume:
- 52
- Issue:
- 7
- Issue Sort Value:
- 2013-0052-0007-0000
- Page Start:
- 1287
- Page End:
- 1292
- Publication Date:
- 2013-10
- Subjects:
- Oncology -- Periodicals
Cancer -- Treatment -- Periodicals
616.992 - Journal URLs:
- http://informahealthcare.com/loi/onc ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/0284186X.2013.824608 ↗
- Languages:
- English
- ISSNs:
- 0284-186X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0641.705000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3729.xml